Deminor opens German office and welcomes Dr. Malte Stübinger to further develop activities in Germany

Malte Stübinger brings additional experience and expertise in commercial, securities and antitrust litigation to help grow Deminor’s presence in the German litigation funding market.

Deminor is pleased to announce the opening of an office in Hamburg and the appointment of Malte Stübinger as Senior Legal Counsel. Malte will join the existing team dedicated to the German litigation funding market consisting of Felix von Zwehl, Bruno Wagner and Jasmin Hansohm.

The opening of the German office and the addition of Malte to the team come at a time of significant growth in demand for Deminor’s litigation funding services in Germany. Both developments underscore our commitment to further expand our activities in this market.

Malte is a qualified attorney (Rechtsanwalt) in Germany and an experienced commercial litigator. He has worked on a broad range of domestic and multinational matters with a particular focus on cross-border securities litigation and antitrust damages disputes. He was previously a Senior Associate at Latham & Watkins in the firm’s Litigation & Trial practice.

He had also been working with the renowned Max Planck Institute for Private International Law for six years. His PhD-thesis analyzed civil liability for aiding and abetting market misrepresentation in Germany and the United States.

About Deminor

Our mission is to restore justice for our clients. Deminor funds and supports individual and group litigation to maximize recoveries for its clients. We are proud of our +80% track record. Our interests are aligned with those of our clients through our transparent and flexible funding structures based on a balanced sharing of risks and potential returns. Our 30+ professionals are located in our offices in Brussels, London, Luxembourg, Milan, Hamburg, Hong Kong and New York.

For further information, please visit: www.deminor.com

Malte can be contacted directly at malte.stuebinger@deminor.com

Introducing a third-party funder into the DBA structure can mitigate these risks. A funded DBA could be agreed at the outset of the case or introduced at later stages, depending on the law firm's needs. Usually, this would involve the funder paying the law firm a portion of its fees through the duration of the proceedings, as well as covering other disbursements, including the upfront premium for an ATE policy to cover adverse cost exposure. Upon the client’s successful recovery, the law firm’s DBA entitlement, for example 30% of the client’s recovery, is then shared between the law firm and the funder in accordance with their funding agreement.

The result is a structure that promotes alignment across all stakeholders, which could result in a more collaborative and economically-focused outcome, while de-risking certain exposures that remain present when using a DBA by itself. The involvement of a third-party funder means that the funder will have independently assessed the likelihood of the claim succeeding on the merits, as well as recoverability and enforcement prospects. This can offer institutional investors comfort (and send defendants a message) that the case is strong and that it has been scrutinised from more than one angle.

As the funding market evolves, DBA structures may become an increasingly useful option for institutional investors seeking to participate in UK securities actions without taking on open ended legal spend or unmanaged adverse cost exposure. However, these arrangements are not one size fits all. Investors will need to consider the economics of the structure, the allocation of control rights, the scope and reliability of adverse cost protection, including ATE insurance and the enforceability of the relevant funding and fee arrangements. A third-party funded DBA can offer a more balanced and commercially aligned route into complex UK securities litigation.

Share